Article
A Conversation about Intersectionality in the Psychedelic Community
A conversation between two (white) activists to further the dialogue around inclusivity in the field of psychedelic research and culture.
Article
A conversation between two (white) activists to further the dialogue around inclusivity in the field of psychedelic research and culture.
Article
Today, we have a world where we can say: “I’m proud to be a woman” and “I’m proud to be gay.” But we can’t say: “I’m a drug-user.”
Article
Like the vast majority of psychonauts, I didn’t use a chemical reagent to verify I was taking LSD, even though I had been active in harm reduction work for three years prior and was aware of testing kits.
Article
Before I met Adam I didn’t really know anyone with OCD. It was just an abstract concept to me. Like most people, I had the image of the stereotypical germaphobe who obsessively scrubs their hands in a futile attempt at washing the thousands of bacteria away.
Article
Rhana Hashemi is the site coordinator for drug and alcohol programs and services for Oakland Unified School District. But, to her students, she is just “the drug lady.”
Article
Vincent Horn of Meditate.io talks about psychedelics and meditation.
Article
When two men entered a party in Uneeda Nichols’ home in Washington, D.C. in August 2017 with a couple hundred dollars in cash, they were greeted as cannabis enthusiasts. No one realized they were undercover cops.
Article
I first discovered the potential psychedelics have for treating stuttering during an experience with psilocybin mushrooms.
Article
A candid talk with Arturo Lua Castillo, named Outstanding Student Organizer of 2018 by Students for Sensible Drug Policy.
Article
Here’s what happened at the first CryptoPsychedelic summit in Tulum, Mexico.
Article
Meet some of the people on the front lines of global drug reform at The Commission on Narcotic Drugs in Vienna.
Article
The Ibogaine Conversation Conclusion | The goal of this conversation was to provide a platform for a diverse range of perspectives on a single topic. Not everyone agrees, and that’s the point.
Psymposia is a research and media 501(c)(3) nonprofit that offers critical perspectives on drugs, politics, and culture.
We rely on audience support to keep our work independent and focused on the public interest. You can sustain Psymposia by becoming a member, which includes exclusive content and perks.